key: cord-0975839-8t2hssqd authors: Samir, Ahmed; Abdel-Gawad, Mohamed Said; Elabd, Amr Magdy; Abed, Walid Mohamed; Mahmoud, Ayman; Gaweesh, Tamer Yousry; Youssef, Ahmed title: Early CT and MRI signs of invasive fungal sinusitis complicating COVID-19 infection: case report date: 2022-01-29 journal: Egypt J Otolaryngol DOI: 10.1186/s43163-022-00206-0 sha: a0bfcf4701d924bbf3cc78c3a5fdf8c67e2731a1 doc_id: 975839 cord_uid: 8t2hssqd BACKGROUND: Corticosteroids are usually prescribed for severe cases with SARS-CoV-2 (COVID-19). Despite their importance to decrease patients’ mortality, they can cause serious side effects like fulminant fungal infection that can damage lungs or invade the sinuses then rapidly spread to the orbit and even intra-cranially. Unless early diagnosed and properly managed, patients can lose their vision or die from cavernous sinus thrombosis or other intracranial complications. CASE PRESENTATION: A 71-year-old diabetic male patient presented with dry cough, fever, and dyspnea for 6 days. PCR test for COVID-19 was ordered and declared positive. The oxygen saturation on day 7 started to decline to reach 90%. Eight ampules of intra-muscular dexamethasone were prescribed. The patient’s dyspnea improved, and the oxygen saturation reached 94% by day 13. Oral prednisone was prescribed in a withdrawal protocol. Unfortunately, on day 15, the patient complained of mild left-sided cheek swelling and noticeably dropped left angle of mouth. Neurological consultation suspected facial palsy and asked for brain MRI examination. Limited lower cuts of the MRI study that covered the left maxillary antrum revealed mild fullness of the pre-maxillary fat planes with mucosal thickening. Complimentary dedicated MRI and CT cuts over the left maxillary sinus showed localized signs of invasive fungal sinusitis without orbital or intracranial complications. The patient received antifungal therapy even before evident endoscopic findings appeared. He underwent endoscopic debridement few days after and he had an excellent outcome without any progression or significant morbidities. CONCLUSION: Early CT/MRI radiological signs of invasive fungal sinusitis that complicated COVID-19 infection aid in the diagnosis and proper timely management of this fatal disease. Corticosteroids are usually prescribed for severe cases with SARS-CoV-2 (COVID-19) who developed rapid oxygen desaturation [1] . Despite their importance to decrease patients' mortality, they can cause harmful side effects, especially in immunocompromised patients. Additional risk factors include uncontrolled diabetes mellitus and neutropenia with or without malignant diseases [2] . One of these side effects is serious, and even fatal is fulminant fungal infection that can damage the lungs or invade the maxillary sinuses then rapidly spread to the orbital cavities and even intra-cranially [3, 4] . Unless early diagnosed and properly managed; patients can lose their vision or die from pulmonary hemorrhage or intracranial complications [5] . Also, radical surgical interventions including radical maxillectomy and orbital exenteration for the sino-orbital involvement would be The Egyptian Journal of Otolaryngology mandatory with questionable outcomes and frustrating facial dysmorphism [6] . The previous literature demonstrated the late cases of sino-orbital mucormycosis. The authors in this case report differently provided the CT and MRI diagnostic signs for early isolated sinus involvement. The authors aimed to highlight the importance of the early clinical and radiological diagnosis before the development of the notorious CT or MRI signs of bony destruction, orbital or intracranial invasion. This early diagnosis could eventually change the clinical decisions and hilariously modify the patients' outcomes. A 71-year-old diabetic male patient presented with dry cough, fever, and dyspnea for 6 days. His CBC laboratory examination revealed leukopenia (WBC = 2.8 × 10 −3 / μl) without lymphopenia (lymphocytes 58%). COVID-19 infection was suspected, and a PCR test for COVID-19 was ordered and declared positive. Home isolation and symptomatic treatment started immediately. The oxygen saturation on day 7 started to decline to reach 90%. Non-contrast chest CT examination was performed. It showed classic CT features of severe COVID-19 infection (Fig. 1) . These CT findings included the following: (1) bilateral widespread peripheral ground glass patches with septal thickening and peri-lobular fibrosis with architectural distortion, (2) reactive mediastinal nodes, (3) mild right-sided and minimal left-sided pleural collection, and (4) cardiomegaly. Eight ampules of intramuscular dexamethasone were prescribed at home when the patient refused hospital admission. Unfortunately, the patient neglected to monitor his blood sugar levels. The patient's dyspnea lately improved, and the oxygen saturation reached 94% by day 13. Oral prednisone was then started in a withdrawal protocol. Unfortunately, on day 15, the patient complained of mild left-sided cheek swelling ( Fig. 2 ) and noticeably dropped left angle of mouth without ocular symptoms or signs. The initial neurological consultation suspected facial palsy and asked for a brain MRI examination. Lower cuts of this study that cover the left maxillary antrum revealed mild fullness of the pre-maxillary fat planes. Complimentary dedicated MRI and CT cuts over the left maxillary sinus showed localized signs of invasive fungal sinusitis without orbital or intracranial complications (Fig. 3) . The MRI findings included the following: (1) left maxillary sinusitis was noted with air-fluid leveling and mucosal thickening that compromised the ostio-meatal complex, (2) fullness and heterogeneous signal of the premaxillary fat with relative mild veiling of the retro-antral fat planes, (3) the left orbital fat planes were still clear, and (4) mild synchronous right maxillary antral mucosal thickening still with clear pre-and retro-antral fat planes. The CT confirmed the MRI findings and added the presence of thinning out of the medial and lateral maxillary walls with small focal areas of bony dehiscence and mild rarefaction that extended posteriorly to the root of the pterygoid plates as well as the left orbital floor. Consultation of ENT service for endoscopic evaluation was achieved. There was no evidence of black eschar along turbinate or nasal septum; however, with high index of suspicion, amphotericin B was immediately prescribed for our patient side by side to insulin injections to control blood sugar levels. Few days after, endoscopic surveillance showed black eschar over middle turbinate and middle meatus on the left side, so the patient was generally fit for an urgent limited endoscopic debridement. The patient did very well for the next weeks after, and he did not need any further procedures. Since declaring the COVID-19 pandemic; respiratory complications were the most common cause of human fatalities [7] . Corticosteroids played a very important role in the modulation of the immune-mediated lung damage caused by the COVID-19 virus and hence decreased human mortality [8] . On the other hand, the incidence of superadded fungal infection had increased especially in the immuno-compromised patients [8, 9] . It could affect the lung yielding a fatal process of alveolar hemorrhage. It also could involve the upper respiratory tract and paranasal sinuses. The invasive form of sinusitis "mucormycosis" caused by this fungal infection can destruct their boundaries with the further spread of infection to the orbital cavities and intra-cranially either directly or along valve-less veins in head and neck region [10] . The patients can lose their vision because of direct infection, optic nerve involvement, or cavernous sinus thrombosis [11] . Furthermore, orbital exenteration could be mandatory during the process of necrotic tissue eradication, which results into a great morbidity to these patients [12] . Additionally, the mortality rates significantly rise as a result of intracranial involvement [13] . Early diagnosis and management can cause a dramatic decrease in morbidity and mortality rates including reversal of immune-suppression states, early antifungal therapy, and surgical debridement of necrotic and fungal tissues [14] . Furthermore, early diagnosis can limit the extent of surgical treatment to endoscopic debridement and avoid major procedures that often result in disfigurement and function loss. Most of the previously published case reports or case series about mucormycosis and COVID-19 infection exhibited the late and complicated forms of the disease with pulmonary, sino-orbital, or intracranial involvement. CT picture of pulmonary alveolar hemorrhage was described with dense ground-glass patches. MRI signs of the sino-orbital invasion included orbital cellulitis, inflammatory pseudo-tumor, optic hydrops, and exophthalmos. MRI signs of enhancing meningo-encephalitic patches were also demonstrated. Radical maxillectomy with orbital exenteration was the main surgical line of treatment [5, [15] [16] [17] [18] [19] [20] [21] . In this case report, the authors provided the early CT and MRI signs for isolated sinus infection. These radiological signs even were present few days before the appearance of endoscopic signs of invasive fungal sinusitis. Eventually, early diagnosis leaded to timely proper clinical management in this case which saved the patient from the intracranial complications and frustrating outcomes such as vision loss and facial dysmorphism. Early CT/MRI radiological signs of invasive fungal sinusitis that complicated COVID-19 infection like fullness and heterogeneous signal of the premaxillary fat with relative mild veiling of the retro-antral fat planes in addition to thinning out of the maxillary sinus walls with small focal areas of bony dehiscence aid in diagnosis and proper timely management of this fatal disease. Abbreviations PCR: Polymerase chain reaction; ENT: Ear, nose, and throat. Surviving sepsis campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) Seminars in respiratory and critical care medicine COVID-19 associated pulmonary aspergillosis (CAPA)-from immunology to treatment Recent advances in the pathogenesis of mucormycoses Mucormycosis with orbital compartment syndrome in a patient with COVID-19 Rhinocerebral mucormycosis: evolution of the disease and treatment options Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Dexamethasone in hospitalized patients with COVID-19-preliminary report Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting Mucormycosis in a diabetic patient: a case report with an insight into its pathophysiology Mold infections of the central nervous system Rhinocerebral mucormycosis: the disease spectrum in 27 patients A fatal case of rhinocerebral mucormycosis of the jaw after dental extractions and review of literature Rhinomaxillary mucormycosis with cerebral extension Coronavirus disease (COVID-19) associated mucormycosis (CAM): case report and systematic review of literature Mucormycosis in patients with COVID-19: a cross-sectional descriptive multicentre study from Iran Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands Rhino-orbital mucormycosis associated with COVID-19 Fulminant mucormycosis complicating coronavirus disease 2019 (COVID-19) Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: a case report Sinoorbital mucormycosis in a COVID-19 patient: a case report Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations Nil. AS is the principal investigator and the main author. MS is a co-author and done the analysis of data. AME is a co-author and done the analysis of data. WM is a co-author and done the literature review and follow up. AM is a co-author and done the literature review and follow up. TY is a co-author and done the data analysis and literature review. AY is the corresponding author and patient care provider and the supervisor of research. None (authors' personal contribution). The data and material are available from the corresponding author on reasonable request.